Latest papers

Paricalcitol for reduction of albuminuria in diabetes.

Paricalcitol for reduction of albuminuria in diabetes

Is nitroglycerin a novel and inexpensive treatment for osteoporosis?

Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening.

Multiple miliary osteoma cutis of the face after initiation of alendronate therapy for osteoporosis.

A sampling of health and medical apps.

Osteoporosis - new treatments and updates.

Atypical fractures on long term bisphosphonates therapy.

The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial

Nonhealing fractures. Promoting growth.

What to make of the new warning on bisphosphonates. Officials acknowledge a connection between the most popular bone drugs and rare thigh fractures.

[Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered].

Chronic indurated gingival ulceration. Bisphosphonate-related osteonecrosis of the jaw (BRONJ).

[Arterial calcification and risk of cardiovascular events in diabetes mellitus].

[Bisphosphonates (BP) and osteonecrosis of the jaws; should administration of BP be discontinued at the early phase?].

Molecular interactions between zoledronic acid and bone: An in vitro Raman microspectroscopic study.

Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases.

[Positioning of bisphosphonates for vascular calcification].

Osteoporosis treatment options expand.

Calcium supplements and heart attack. Opposing studies sound a note of caution on too much calcium.